SEC Form DFiling only, no announcement found
Lurex Bio, based in Fort Lauderdale, FL, reported $150,000 sold in a private offering of equity and debt, with the first sale on January 22, 2026, in a Form D filed with the SEC on August 31, 2026. The filing says 3 investors have already invested. The total offering is stated as Indefinite.
Legal name on the filing: LUREX BIO, INC.
| Amount sold | $150,000Basis: Form D total amount sold, as of the filing of August 31, 2026. Not the announced round size. |
|---|---|
| Total offering | IndefiniteThe most the company may sell under this offering. Not money raised. |
| Securities offered | Equity; Debt |
| Exemption claimed | Rule 506(c) |
| Date of first sale | January 22, 2026 |
| Investors already invested | 3 |
| Non-accredited investors | None |
| Minimum investment accepted | $50,000 |
| Part of a merger or acquisition | No |
| Industry group | Biotechnology |
| Principal place of business | Fort Lauderdale, FL |
| Jurisdiction of incorporation | DELAWARE |
| Entity type | Corporation |
| Year of incorporation | 2025 |
| Revenue range | No Revenues |
| SEC CIK | 2108090 |
Round name, valuation, lead investor and participants are not on a Form D, so they are not shown. They appear here only when a press or company announcement is matched to this deal.
| Name, as filed | Relationship | VC Beast profile |
|---|---|---|
| George Sens | Executive OfficerChief Executive Officer | None linked |
| Mark Shumate | Executive Officer, DirectorVice President, Capital and Strategic Partnerships | None linked |
| Horace Lanier, III | Executive Officer, DirectorChief Operating Officer and Secretary | None linked |
| James Clark | PromoterFounder; took the initiative in founding and organizing Lurex Bio, Inc. | None linked |
Form D lists the company's executive officers, directors and promoters. A director is often an investor's board representative, but the filing does not say who invested.
| Filed | Form | Amount sold | Total offering |
|---|---|---|---|
| Aug 31, 2026 | D/A (amendment) | $150,000 | Indefinite |
The latest filing states the current amount sold; an amendment replaces the figure before it.
From the issuer's EDGAR filing history. Amounts are shown for filings in our warehouse, which holds operating-company filings from July 16, 2026.
Filing only, no announcement found. The only source for this deal is the company's own SEC filing, made under penalty of law. When a press or company announcement is matched to it, it is cited here with the round name it gives.
Amount sold is the filing's total amount sold; total offering is its authorized maximum. This page was built from filings received through September 29, 2026. Report an error on the corrections page.
Cite this deal
VC Beast, "Lurex Bio: SEC Form D deal record", https://vcbeast.com/deals/lurex-bio-form-d-2026-01-22. Source: SEC EDGAR, accession 0002108090-26-000004.